![Candesartan Cilexetil and Hydrochlorothiazide Tablets 16mg/12.5mg Taj Pharma - Taj Generics Pharmaceuticals | Taj Pharma Candesartan Cilexetil and Hydrochlorothiazide Tablets 16mg/12.5mg Taj Pharma - Taj Generics Pharmaceuticals | Taj Pharma](https://tajgenerics.com/wp-content/uploads/Candesartan-Cilexetil-Hydrochlorothiazide-Tablets-16-mg-12.5-mg-Taj-Pharma.jpg)
Candesartan Cilexetil and Hydrochlorothiazide Tablets 16mg/12.5mg Taj Pharma - Taj Generics Pharmaceuticals | Taj Pharma
![Aminotransferase progression. Candesartan was started on day 0 at 8mg/day. | Download Scientific Diagram Aminotransferase progression. Candesartan was started on day 0 at 8mg/day. | Download Scientific Diagram](https://www.researchgate.net/publication/319293112/figure/fig2/AS:669117656879109@1536541489543/Aminotransferase-progression-Candesartan-was-started-on-day-0-at-8mg-day.png)
Aminotransferase progression. Candesartan was started on day 0 at 8mg/day. | Download Scientific Diagram
![Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fhr.2011.120/MediaObjects/41440_2011_Article_BFhr2011120_Fig1_HTML.jpg)
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research
![Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - The Lancet Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - The Lancet](https://www.thelancet.com/cms/attachment/2119436295/2093788133/gr1.gif)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - The Lancet
![Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension](https://www.ahajournals.org/cms/asset/0ef8273d-3a19-4f72-9574-cc4ad16fadd2/hypertensionaha.122.19105.fig03.jpg)
Differential Sex-Specific Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin Receptor Blocker Therapy on Arterial Function in Hypertension: CALIBREX Trial | Hypertension
![Frontiers | Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4 Frontiers | Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4](https://www.frontiersin.org/files/Articles/628403/fnins-15-628403-HTML/image_m/fnins-15-628403-g001.jpg)
Frontiers | Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4
![Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fhr.2011.120/MediaObjects/41440_2011_Article_BFhr2011120_Fig2_HTML.jpg)
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research
![Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - ScienceDirect Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0140673603142821-gr2.gif)
Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme - ScienceDirect
![Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fhr.2011.120/MediaObjects/41440_2011_Article_BFhr2011120_Fig3_HTML.jpg)
Long-term effects of candesartan and amlodipine on cardiovascular morbidity and mortality in Japanese high-risk hypertensive patients: the Candesartan Antihypertensive Survival Evaluation in Japan Extension Study (CASE-J Ex) | Hypertension Research
![PDF] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial | Semantic Scholar PDF] Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/569ebf85700d1ed65585fd33c90b0480ff26f05b/2-Figure1-1.png)